What question did this study set out to answer?

The aim is to explore the FDA's draft guidance on Bayesian methods in clinical trials.

March 25, 2026JAMA0 citations

FDA Draft Guidance for the Use of Bayesian Methods in Clinical Trials

AGAndrew Gelman EZErik van Zwet WWWitold Więcek

Key Points

The aim is to explore the FDA's draft guidance on Bayesian methods in clinical trials.
Analysis of the FDA draft guidance document
Discussion of implications for therapeutic testing
Highlights the importance of Bayesian methods in clinical trials
Discusses potential benefits for evaluating new therapeutics

Abstract

This Perspective discusses the draft guidance for industry that the US Food and Drug Administration released on the use of bayesian methods in testing therapeutics.

问 AI

Bookmark

View Full Paper